Order Article Reprints

Netti GS, Soccio P, Catalano V, De Luca F, Khalid J, Camporeale V, Moriondo G, Papale M, Scioscia G, Corso G, et al. The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study. Biomedicines. 2024; 12(6):1306. https://doi.org/10.3390/biomedicines12061306

Netti, Giuseppe Stefano, Piera Soccio, Valeria Catalano, Federica De Luca, Javeria Khalid, Valentina Camporeale, Giorgia Moriondo, Massimo Papale, Giulia Scioscia, Gaetano Corso, and et al. 2024. "The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study" Biomedicines 12, no. 6: 1306. https://doi.org/10.3390/biomedicines12061306

Netti, G. S., Soccio, P., Catalano, V., De Luca, F., Khalid, J., Camporeale, V., Moriondo, G., Papale, M., Scioscia, G., Corso, G., Foschino, M. P., Lo Caputo, S., Lacedonia, D., & Ranieri, E. (2024). The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study. Biomedicines, 12(6), 1306. https://doi.org/10.3390/biomedicines12061306